Selected Publications

Ribal MJ, Rosenberg J, Ajami T, Vilaseca A, Xia L, Sternschuss M, Schuckman AK: Advancing perioperative treatment options for localized muscle-invasive bladder cancer: A step forward. American Society of Clinical Oncology Educational Book 45(3): e472822, June 2025 Notes: Epub May 20, 2025.

Doshi C, Zahir M, Dadabhoy A, Xia L, Miranda G, Cai J, Daneshmand S: Evaluation of the potential impact of care fragmentation on survival outcomes in muscle invasive bladder cancer patients. Urologic Oncology: Seminars & Original Investigations 43(3 Suppl): 44, Mar. 2025 Notes: Presented at the 25th Annual Meeting of the Society of Urology (SUO), Dallas, TX, Dec. 2024.

Davis R, Xia L, Miranda G, Cai J, Daneshmand S: Outcomes following neoadjuvant cisplatin-based chemotherapy and cystectomy for muscle invasive urothelial carcinoma with concomitant carcinoma in situ. Urologic Oncology: Seminars & Original Investigations 43(3 Suppl): 18-19, Mar. 2025 Notes: Presented at the 25th Annual Meeting of the Society of Urology (SUO), Dallas, TX, Dec. 2024.

Xia L, Dadabhoy A, Molina LS, Wood E, Lee Y, Miranda G, Cai J, Djaladat H, Schuckman A, Daneshmand S: Level of nodal metastasis in patients undergoing radical cystectomy and lymphadenectomy: Is there a role of extended lymphadenectomy in the post-S1011 era? Urologic Oncology: Seminars & Original Investigations 43(3 Suppl): 19, Mar. 2025 Notes: Presented at the 25th Annual Meeting of the Society of Urology (SUO), Dallas, TX, Dec. 2024.

Doshi C, Dadabhoy A, Moghaddam FS, Wood E, Xia L, Daneshmand S: Assessing the diagnostic utility of cxbladder monitor as an alternative to surveillance cystoscopy. Urologic Oncology: Seminars & Original Investigations 43(3 Suppl): 94, Mar. 2025 Notes: Presented at the 25th Annual Meeting of the Society of Urology (SUO), Dallas, TX, Dec. 2024.

Doshi C, Dadabhoy A, Ladi-Seyedian S, Xia L, Schuckman A, Daneshmand S: Alopecia as an uncommon side effect of single postoperative instillation of gemcitabine in patients with non-muscle invasive urothelial carcinoma of the bladder: A multi-institution experience. Urologic Oncology: Seminars & Original Investigations 43(3 Suppl): 93-94, Mar. 2025 Notes: Presented at the 25th Annual Meeting of the Society of Urology (SUO), Dallas, TX, Dec. 2024.

Doshi C, Zahir M, Escobar D, Xia L, Daneshmand S: Complications after transurethral resection of bladder tumor: Findings from the 2022 ACS NSQIP database. Journal of Clinical Oncology 43(Suppl 5), Feb. 2025 Notes: Presented at the 2025 American Society of Clinical Oncology ASCO Genitourinary Cancers Symposium, San Francisco, CA, Feb. 2025.

Doshi C, Zahir M, Dadabhoy A, Escobar D, Xia L, Daneshmand S: Serum tumor markers for muscle-invasive bladder cancer in clinical practice: A narrative review. Cancers (Basel) 17(5): 728, Feb. 21 2025.

Ku J, Doshi C, Dadabhoy A, Xia L, Daneshmand S: Clinicopathological variations between early and late recurrence in bladder cancer post-radical cystectomy. Journal of Clinical Oncology 43(Suppl 5), Feb. 2025 Notes: Presented at the 2025 American Society of Clinical Oncology ASCO Genitourinary Cancers Symposium, San Francisco, CA, Feb. 2025.

Zahir M, Doshi C, Escobar D, Xia L, Miranda G, Cai J, Schuckman AK, Djaladat H, Daneshmand S: Evaluating the survival benefits of adjuvant immunotherapy in muscle-invasive urothelial carcinoma: A real-world experience. Journal of Clinical Oncology 43(Suppl 5), Feb. 2025 Notes: Presented at the 2025 American Society of Clinical Oncology ASCO Genitourinary Cancers Symposium, San Francisco, CA, Feb. 2025.